Lenz Therapeutics

PharmaceuticalsSeries BUSlenz-tx.com

Latest round

Series B

Last raised

Mar 2023

Total raised

$131M

Investors

6

About Lenz Therapeutics

Founded in 2013 and based in California, US, Lenz Therapeutics, Inc. develops an aceclidine-based eye drop that provides treatment for loss of near vision associated with presbyopia.D, and James McCollum. Mr. Eef Schimmelpennink serves as the CEO of Lenz Therapeutics. Mr. Schimmelpennink served as the former CEO of Alvotech, a pharmaceutical company. The company's product is an aceclidine-based eye drop that helps in restoring the vision of a person that was lost from a condition called Presbyopia. The solution targets the pinhole pupil located near the contracted iris muscles that will focus on the retina as a surrogate for accommodation. The company's revenue is generated by the sales of the eye drops in the market specifically for persons that suffer from Presbyopia. The company plans to enlist its aceclidine product towards an NDA submission.

Who invested in Lenz Therapeutics

6 investors across 2 rounds

See all investors in Lenz Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 6, 2023

    Amount

    $84M

    Investors

    Locked

  2. Series A

    Jun 17, 2021

    Amount

    $47M

    Investors

    Locked

Questions about Lenz Therapeutics

Who invested in Lenz Therapeutics?

Lenz Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Lenz Therapeutics raised?

Lenz Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Lenz Therapeutics last raise money?

Lenz Therapeutics's most recent round on record is a Series B, in Mar 2023.

What does Lenz Therapeutics do?

Founded in 2013 and based in California, US, Lenz Therapeutics, Inc.

Where is Lenz Therapeutics headquartered?

Lenz Therapeutics is headquartered in US.

Which VCs invest in companies like Lenz Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Lenz Therapeutics's stage. Their profiles are linked below.

Raising like Lenz Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.